Human ADORA2A/A2aR/ADORA2 ORF/cDNA clone-Adeno-associate virus(AAV) particle (NM_001278497)
Cat. No.: vGMAAV001052
Pre-made Human ADORA2A/A2aR/ADORA2 Adeno-associated virus particle for ADORA2A in-vivo study, mechanism of action (MOA) research and ADORA2A-associated gene therapy development.
At GM Vector Core (GMVC), we stand at the forefront of custom AAV development and produce distinct grades of AAVs employing state-of-the-art methodologies. Uncover more about our expertise.
Go to
ADORA2A/A2aR products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | AAV serotype | AAV Grade | AAV quantity |
vGMAAV001052 | Human ADORA2A Adeno-associate virus(AAV) particle | AAV1, AAV2, AAV2 variant (Y444F), AAV2 variant (Y272F, Y444F, Y500F, Y730F), AAV2 variant (Y444F, Y730F, Y500F, Y272F, Y704F, Y252F), AAV2 variant(AAV2.7m8), AAV5, AAV6, AAV8, AAV8-1m, AAV8-2m, AAV8 variant (Y733F, Y447F, Y275), AAV9, AAV-Rh.10, AAV-DJ, AAV-DJ/8, AAV-Retro (Retrograde), AAV9-PHP.B, AAV9-PHP.eB, AAV9-PHP.S, AAV-BR1, AAV-2i8, AAV-SIG, AAV-VEC, AAV4, AAV6.2, AAV6.2FF | Pilot Grade | 1.0E+12VG/ml |
5.0E+12VG/ml | ||||
1E+13VG/ml | ||||
5E+13VG/ml | ||||
1E+14VG/ml | ||||
Research Grade | 1.0E+12VG/ml | |||
5.0E+12VG/ml | ||||
1E+13VG/ml | ||||
5E+13VG/ml | ||||
1E+14VG/ml | ||||
GMP-like Grade | inquiry | |||
GMP Grade | inquiry |
Product Description
Catalog ID | vGMAAV001052 |
Gene Name | ADORA2A |
Accession Number | NM_001278497 |
Gene ID | 135 |
Species | Human |
Product Type | Adeno-associate virus(AAV) particle (overexpression) |
Insert Length | 1239 bp |
Gene Alias | A2aR,ADORA2,RDC8 |
Fluorescent Reporter | ZsGreen |
Mammalian Cell Selection | Null |
Fusion Tag | Null |
Promoter | hSyn |
Resistance | Amplicin |
ORF Nucleotide Sequence | ATGCCCATCATGGGCTCCTCGGTGTACATCACGGTGGAGCTGGCCATTGCTGTGCTGGCCATCCTGGGCAATGTGCTGGTGTGCTGGGCCGTGTGGCTCAACAGCAACCTGCAGAACGTCACCAACTACTTTGTGGTGTCACTGGCGGCGGCCGACATCGCAGTGGGTGTGCTCGCCATCCCCTTTGCCATCACCATCAGCACCGGGTTCTGCGCTGCCTGCCACGGCTGCCTCTTCATTGCCTGCTTCGTCCTGGTCCTCACGCAGAGCTCCATCTTCAGTCTCCTGGCCATCGCCATTGACCGCTACATTGCCATCCGCATCCCGCTCCGGTACAATGGCTTGGTGACCGGCACGAGGGCTAAGGGCATCATTGCCATCTGCTGGGTGCTGTCGTTTGCCATCGGCCTGACTCCCATGCTAGGTTGGAACAACTGCGGTCAGCCAAAGGAGGGCAAGAACCACTCCCAGGGCTGCGGGGAGGGCCAAGTGGCCTGTCTCTTTGAGGATGTGGTCCCCATGAACTACATGGTGTACTTCAACTTCTTTGCCTGTGTGCTGGTGCCCCTGCTGCTCATGCTGGGTGTCTATTTGCGGATCTTCCTGGCGGCGCGACGACAGCTGAAGCAGATGGAGAGCCAGCCTCTGCCGGGGGAGCGGGCACGGTCCACACTGCAGAAGGAGGTCCATGCTGCCAAGTCACTGGCCATCATTGTGGGGCTCTTTGCCCTCTGCTGGCTGCCCCTACACATCATCAACTGCTTCACTTTCTTCTGCCCCGACTGCAGCCACGCCCCTCTCTGGCTCATGTACCTGGCCATCGTCCTCTCCCACACCAATTCGGTTGTGAATCCCTTCATCTACGCCTACCGTATCCGCGAGTTCCGCCAGACCTTCCGCAAGATCATTCGCAGCCACGTCCTGAGGCAGCAAGAACCTTTCAAGGCAGCTGGCACCAGTGCCCGGGTCTTGGCAGCTCATGGCAGTGACGGAGAGCAGGTCAGCCTCCGTCTCAACGGCCACCCGCCAGGAGTGTGGGCCAACGGCAGTGCTCCCCACCCTGAGCGGAGGCCCAATGGCTATGCCCTGGGGCTGGTGAGTGGAGGGAGTGCCCAAGAGTCCCAGGGGAACACGGGCCTCCCAGACGTGGAGCTCCTTAGCCATGAGCTCAAGGGAGTGTGCCCAGAGCCCCCTGGCCTAGATGACCCCCTGGCCCAGGATGGAGCAGGAGTGTCCTGA |
ORF Protein Sequence | MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAITISTGFCAACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKNHSQGCGEGQVACLFEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFLAARRQLKQMESQPLPGERARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQQEPFKAAGTSARVLAAHGSDGEQVSLRLNGHPPGVWANGSAPHPERRPNGYALGLVSGGSAQESQGNTGLPDVELLSHELKGVCPEPPGLDDPLAQDGAGVS |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
---|---|---|
Target Antibody | GM-Tg-g-T77365-Ab | Anti-AA2AR/ ADORA2A/ A2aR monoclonal antibody |
Target Antigen | GM-Tg-g-T77365-Ag | ADORA2A VLP (virus-like particle) |
ORF Viral Vector | pGMAAV000023 | Human ADORA2A Adeno-associate virus(AAV) plasmid |
ORF Viral Vector | pGMAAV000313 | Human ADORA2A Adeno-associate virus(AAV) plasmid |
ORF Viral Vector | pGMAAV001052 | Human ADORA2A Adeno-associate virus(AAV) plasmid |
ORF Viral Vector | pGMAP000328 | Human ADORA2A Adenovirus plasmid |
ORF Viral Vector | vGMAAV000023 | Human ADORA2A Adeno-associate virus(AAV) particle |
ORF Viral Vector | vGMAAV000313 | Human ADORA2A Adeno-associate virus(AAV) particle |
ORF Viral Vector | vGMAAV001052 | Human ADORA2A Adeno-associate virus(AAV) particle |
ORF Viral Vector | vGMAP000328 | Human ADORA2A Adenovirus particle |
Target information
Target ID | GM-T77365 |
Target Name | ADORA2A |
Gene Group Identifier (Target Gene ID in Homo species) |
135 |
Gene ID |
100034039 (Equus caballus), 101080742 (Felis catus), 11540 (Mus musculus), 135 (Homo sapiens) 25369 (Rattus norvegicus), 403960 (Canis lupus familiaris), 617828 (Bos taurus), 707865 (Macaca mulatta) |
Gene Symbols & Synonyms | ADORA2A,Adora2a,A2aR,A2AAR,AA2AR,ARA2A,RDC8,ADORA2,A2ar,ADENO,Adora2l1 |
Target Alternative Names | ADORA2A,Adenosine receptor A2a,A2aR,RDC8,ADORA2 |
Uniprot Accession |
P11617,P29274,P30543,Q60613,Q6TLI7
Additional SwissProt Accessions: Q6TLI7,Q60613,P29274,P30543,P11617 |
Uniprot Entry Name | |
Protein Sub-location | Transmembrane Protein |
Category | Therapeutics Target, Immuno-oncology Target |
Disease | |
Disease from KEGG | Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction |
Gene Ensembl | ENSECAG00000034739, ENSMUSG00000020178, ENSG00000128271, ENSCAFG00845022393, ENSBTAG00000016944, ENSMMUG00000008516 |
Target Classification | GPCR, Checkpoint-Immuno Oncology |
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.